PHARMACEUTICAL ORAL SOLID PREPARATION FORM, METHOD FOR PRODUCING IT, METHOD FOR TREATING OR PREVENTING THE DIGESTIVE SYSTEM WITH ITS HELP, TEMPORARY TABLE, TABLET
1. A pharmaceutical oral solid formulation comprising a core that contains benzimidazole or a derivative thereof, a separation layer that contains a water-soluble polymer and glyceryl monostearate, and an enteric coating. The form according to claim 1, wherein the benzimidazole or its derivative is a physiologically active benzimidazole derivative of the formula (1), its salts or stereoisomers (1) where R is hydrogen, methoxy or difluoromethoxy, R is methyl or methoxy, R is methoxy, 2, 2, 2 - trifluoroethoxy or 3 - methoxypropoxy and R is hydrogen or methyl. 3. A form according to claim 2, wherein the benzimidazole derivative is selected from the group of derivatives including omeprazole, rabeprazole, lansoprazole and pantoprazole, their salts or stereoisomers. The form of claim 2, wherein the benzimidazole derivative is esomeprazole sodium salt. The form of claim 1, wherein the water soluble polymer is cellulose, preferably hydroxypropyl methyl cellulose. The form according to claim 1, in which glyceryl monostearate is contained in an amount of from 2% to 60% of the mass. by weight of the total water-soluble polymer. 7. A mold according to claim 1, which contains at least one additional layer. The form according to claim 7, in which the additional layer contains a mixture of 2, 3 or 4 different polyethylene glycol polymers. The form according to claim 1, in which the core contains an inert granule and / or alkaline compound. The form according to claim 1, which is a pill, granule, tablet or minitable. A method of obtaining a mold according to any one of claims 1 to 10, including the process of water layering. 12. The use of the form according to any one of claims 1 to 10 as �1. Фармацевтическая пероральная твердая препаративная форма, включающая ядро, которое содержит бензимидазол или его производное, разделяющий слой, который содержит водорастворимый полимер и глицерилмоностеарат, и энтеросолюбильное покрытие.2. Форма по п.1, в котором бензимидазол или его произво
